Related Experiment Video
Updated: Aug 11, 2026
10:12
A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
Published on: October 31, 2012
Advances in noninvasive pulmonary gene therapy
1cdensmore@houston.rr.com
Current Drug Delivery
|February 14, 2006
Summary
Inhaled gene therapy using polyethyleneimine (PEI) vectors shows promise for treating lung diseases and tumors. This non-invasive method effectively delivers genes to lung cells with low toxicity and minimal immune response.
Area of Science:
- Biotechnology
- Gene Therapy
- Pulmonary Medicine
Background:
- Inhalation offers a non-invasive route for drug and gene delivery, particularly for pulmonary disorders.
- Early gene therapy efforts via inhalation faced challenges like nebulization forces and mucus barriers.
- Recent advancements have enabled successful delivery of various viral and nonviral vectors through inhalation.
Purpose of the Study:
- To evaluate the efficacy and safety of aerosolized gene delivery using polyethyleneimine (PEI) vectors for lung conditions.
- To explore the potential of inhaled gene therapy for treating pulmonary diseases and non-pulmonary conditions via secreted proteins.
- To assess the therapeutic response in animal models and investigate localized genetic immunization potential.
Main Methods:
- Utilized polyethyleneimine (PEI)-based formulations for aerosolized gene delivery.
- Administered PEI complexes of p53 and IL-12 genes via nebulization in animal lung tumor models.
- Evaluated transfection efficiency in airway epithelial cells and lung parenchyma.
- Assessed therapeutic responses, toxicity, and immunostimulatory effects.
Main Results:
- PEI formulations demonstrated stability during nebulization and high transfection rates in airway epithelial cells.
- Significant transfection was observed in the lung parenchyma, with therapeutic responses in animal lung tumor models.
- Inhalation delivery showed surprisingly low toxicity and minimal immunostimulatory response to bacterial plasmid DNA.
Conclusions:
- Aerosolized gene delivery using PEI vectors is a promising non-invasive approach for treating lung diseases and tumors.
- This method offers advantages over invasive delivery, including potential for localized genetic immunization.
- The low toxicity and immune response of PEI-based inhalation gene therapy support its potential for repeated administration.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...